SCHEMBL5776467

SCHEMBL5776467

[O-][n+]1cc(Br)cc(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
MAPK1 P28482 3/20 0.44
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PARP1 P09874 1/20 0.34
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8249688 0.75 MAOA (0.50) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL417479 0.74
SCHEMBL5779052 0.73 TSHR (0.32) TSHR
SCHEMBL11544480 0.71 LTA4H (0.44) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL3741855 0.71 KMO (0.53) KMT2AMEN1TSHRPARP1
SCHEMBL45718 0.69 ALDH1A1 (0.60) ALDH1A1MAPK1CRHBPCRHR2NPC1
SCHEMBL1562747 0.69 ALDH1A1 (0.60) ALDH1A1MAPK1KMT2AMEN1CRHBP
SCHEMBL28199592 0.69 ALDH1A1 (0.58) ALDH1A1MAPK1KMT2AMEN1CRHBP
SCHEMBL1585710 0.69 L3MBTL1 (0.50) ALDH1A1KMT2AMEN1CA12CA1
SCHEMBL5164 0.67 ALDH1A1 (0.57) ALDH1A1MAPK1KMT2AMEN1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482456-B2 antiasthmatic; antiinflammatory; minimal side effects; 8-(3-{2-(3-chlorophenyl)-4-[4-(methylsulfonyl)phenyl]-1,3-thiazol-5-yl}phenyl)-6-[1-methyl-1-(methylsulfonyl)ethyl]quinoline; 2-[5-(3-{6-[1-methyl-1-(methylsulfonyl)ethyl]quinolin-8-yl}phenyl)-4-pyridin-3-yl-1,3-thiazol-2-yl]propan-2-ol MERCK FROSST CANADA 2009-01-27 US disclosed
CN-100441185-C 8- (3-biaryl) phenylquinoline phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2008-12-10 CN disclosed
CN-1812787-A 8- (3-biaryl) phenylquinoline phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2006-08-02 CN disclosed
EP-1635829-A1 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS Merck Frosst Canada Ltd. (CA) 2006-03-22 EP disclosed
WO-2004096220-A1 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS MERCK FROSST CANADA LTD. (CA) 2004-11-11 WO disclosed